Cargando…

Recurrent Omental Hemangiopericytoma: A Therapeutic Challenge

Hemangiopericytomas are vascular tumors with a susceptibility to arise anywhere in the human body. We present a case of a 68-year-old female with primary omental hemangiopericytoma and a two-time recurrence managed with surgery and close follow-up. The first recurrence was at 52 months and the secon...

Descripción completa

Detalles Bibliográficos
Autores principales: Jaber, Sara, Winer, Ira, Rasool, Nabila
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4819095/
https://www.ncbi.nlm.nih.gov/pubmed/27088021
http://dx.doi.org/10.1155/2016/2075157
_version_ 1782425138530091008
author Jaber, Sara
Winer, Ira
Rasool, Nabila
author_facet Jaber, Sara
Winer, Ira
Rasool, Nabila
author_sort Jaber, Sara
collection PubMed
description Hemangiopericytomas are vascular tumors with a susceptibility to arise anywhere in the human body. We present a case of a 68-year-old female with primary omental hemangiopericytoma and a two-time recurrence managed with surgery and close follow-up. The first recurrence was at 52 months and the second at 37 months following the prior presentation. No adjuvant chemotherapy or radiation therapy was administered. Given the widespread nature of the cell of origin, routine follow-up postoperatively with interval imaging in order to detect recurrences is imperative. Pathologic tumor characteristics may determine potential for recurrence and may also assist in determining whether adjuvant treatment modalities should be included in the management plan. Review of the English literature reveals a total of 24 cases of omental hemangiopericytomas inclusive of the current report.
format Online
Article
Text
id pubmed-4819095
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-48190952016-04-17 Recurrent Omental Hemangiopericytoma: A Therapeutic Challenge Jaber, Sara Winer, Ira Rasool, Nabila Case Rep Obstet Gynecol Case Report Hemangiopericytomas are vascular tumors with a susceptibility to arise anywhere in the human body. We present a case of a 68-year-old female with primary omental hemangiopericytoma and a two-time recurrence managed with surgery and close follow-up. The first recurrence was at 52 months and the second at 37 months following the prior presentation. No adjuvant chemotherapy or radiation therapy was administered. Given the widespread nature of the cell of origin, routine follow-up postoperatively with interval imaging in order to detect recurrences is imperative. Pathologic tumor characteristics may determine potential for recurrence and may also assist in determining whether adjuvant treatment modalities should be included in the management plan. Review of the English literature reveals a total of 24 cases of omental hemangiopericytomas inclusive of the current report. Hindawi Publishing Corporation 2016 2016-03-21 /pmc/articles/PMC4819095/ /pubmed/27088021 http://dx.doi.org/10.1155/2016/2075157 Text en Copyright © 2016 Sara Jaber et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Jaber, Sara
Winer, Ira
Rasool, Nabila
Recurrent Omental Hemangiopericytoma: A Therapeutic Challenge
title Recurrent Omental Hemangiopericytoma: A Therapeutic Challenge
title_full Recurrent Omental Hemangiopericytoma: A Therapeutic Challenge
title_fullStr Recurrent Omental Hemangiopericytoma: A Therapeutic Challenge
title_full_unstemmed Recurrent Omental Hemangiopericytoma: A Therapeutic Challenge
title_short Recurrent Omental Hemangiopericytoma: A Therapeutic Challenge
title_sort recurrent omental hemangiopericytoma: a therapeutic challenge
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4819095/
https://www.ncbi.nlm.nih.gov/pubmed/27088021
http://dx.doi.org/10.1155/2016/2075157
work_keys_str_mv AT jabersara recurrentomentalhemangiopericytomaatherapeuticchallenge
AT winerira recurrentomentalhemangiopericytomaatherapeuticchallenge
AT rasoolnabila recurrentomentalhemangiopericytomaatherapeuticchallenge